Sunday, February 18, 2024 2:45:49 PM
People blow these things so wildly out of proportion sometimes. Especially, certain moderators on here who like to ban people for disagreeing with them, but it's really just because they don't understand common business practices that happen all the time. As long as you disclose your interest, that usually removes any conflict of interest. People conflate that with legal bias and a conflict that would warrant a judge/DA etc. recusing themselves from the proceeding. A business and/or business owner can have similar businesses and act in both of their best interests. When there are questions that would create a conflict, the board steps in and puts an outside set of eyes on it.
Now, all that being said, you can do something completely legal, completely above board, and even have a nearly impossible goal set up for your CEO to ensure that it is clear that your interest as the CEO is to do well for the company and still get your hand slapped by a judge who has no idea about anything about business and wishes to use their position of power to punish a capitalist system that you loathe. For instance, everyone was talking about how bad the deal for Elon Musk was when he put his compensation out for vote. Everyone was saying how impossible it was to meet all of his metrics that were approved by the board. The market thought those metrics were impossible as well - that's why it was the most shorted stock in the country. Then, after he hit all of his numbers and made it one of the biggest companies in the world, a shareholder with 9 shares (more shares than some on this board) sued Tesla and said Elon didn't deserve his $55 billion pay package.
Now, all that being said, you can do something completely legal, completely above board, and even have a nearly impossible goal set up for your CEO to ensure that it is clear that your interest as the CEO is to do well for the company and still get your hand slapped by a judge who has no idea about anything about business and wishes to use their position of power to punish a capitalist system that you loathe. For instance, everyone was talking about how bad the deal for Elon Musk was when he put his compensation out for vote. Everyone was saying how impossible it was to meet all of his metrics that were approved by the board. The market thought those metrics were impossible as well - that's why it was the most shorted stock in the country. Then, after he hit all of his numbers and made it one of the biggest companies in the world, a shareholder with 9 shares (more shares than some on this board) sued Tesla and said Elon didn't deserve his $55 billion pay package.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
